From striking surgeons in Palakkad to antidepressant shortages in the UK, failing infrastructure and supply chain fragility are undermining patient care and medical professional stability.
The fundamental promise of modern medicine—that a patient in need will receive timely, evidence-based care—is increasingly under siege by administrative failures and infrastructure neglect. In Palakkad, house surgeons continued their strike on September 2, 2026, after the medical college failed to provide basic diagnostic services, including X-ray and scanning capabilities. The protest was sparked when two accident victims were transferred to another facility because the hospital lacked the necessary tools to treat them.
This breakdown in service represents a systemic failure to maintain the physical capital required for medical practice. When a hospital cannot perform a simple X-ray, the burden falls on frontline providers and patients. The surgeons’ demand for infrastructure upgrades is a necessary plea for the tools required to fulfill their professional oaths, illustrating how government-managed facilities often struggle to keep pace with basic technological requirements.
While infrastructure crumbles in some regions, others grapple with the fragility of the global pharmaceutical supply chain. In the United Kingdom, a major shortage of the antidepressant Venlafaxine is expected to persist until November. Such shortages are a stark reminder of the risks inherent in centralized procurement and the lack of diverse manufacturing incentives. For patients, these disruptions are life-altering interruptions that can lead to withdrawal symptoms and mental health crises. The market’s inability to maintain stock highlights a need for greater transparency and competition to ensure life-sustaining medications remain accessible.
In the United States, the healthcare landscape is shifting through consolidation and corporate policy changes. Select Medical and Corewell Health recently announced a joint venture for an 84-bed inpatient rehabilitation hospital in Michigan. While providing new facilities, this trend toward consolidation raises questions about market competition and long-term pricing. Simultaneously, corporate decisions are impacting patient access. The Obesity Action Coalition has called on PepsiCo to reverse its decision to end coverage for GLP-1 obesity medications for certain employees, highlighting how insurance design can abruptly change the cost-benefit analysis for patients relying on new therapies.
Even as new specialty centers like the Pratheeksha Centres in Keralam aim to provide 24×7 care, underlying issues of staffing and professional conduct remain. At Kottarakara Taluk Hospital, a duty doctor faces departmental action following a confrontation with a patient, straining the trust necessary for effective care. These conflicts often mask deeper systemic stressors, such as overcrowding and administrative pressure, which erode the sacred doctor-patient relationship. Furthermore, the Keralam Cabinet’s decision to set up new Narcotic Drugs and Psychotropic Substances Act special courts underscores the growing intersection between healthcare and the legal challenges of the addiction crisis.
Technological integration offers hope, as seen in the partnership between nference and the Rush University System for Health to advance AI-enabled research. However, for these advancements to matter, the foundations of care must be secured. Whether it is the absence of diagnostic machines, the lack of essential pills, or the erosion of insurance coverage, the common thread is a system that too often prioritizes administrative convenience over individual patient needs. Restoring healthcare integrity requires a return to fundamentals: robust infrastructure, transparent pricing, and a resilient supply chain that respects medical autonomy.
Susan Carter serves as a Senior Correspondent for Just Right News, where she leads the network’s comprehensive coverage of Health, Medicine, and Public Policy. With a career dedicated to dissecting the complexities of the American healthcare system, Susan brings a principled perspective to the most pressing debates of the day. Her reporting is characterized by a commitment to individual liberty, fiscal responsibility, and a healthy skepticism of government overreach, making her a vital voice for audiences seeking clarity in an increasingly regulated landscape.
Raised in Minneapolis, Minnesota, Susan’s professional outlook is deeply informed by the values of the American heartland. Growing up in the Twin Cities, she witnessed firsthand the importance of community-driven solutions and the resilience of the individual. This Midwestern foundation instilled in her a firm belief that the best answers to public policy challenges often come from local innovation and personal responsibility rather than top-down federal mandates. Her background allows her to translate complex legislative jargon into stories that resonate with families who value common sense and local autonomy.
Now based in Baltimore, Maryland, Susan operates from a unique vantage point at the intersection of medical innovation and urban policy. Living and working in a city renowned for its world-class medical institutions and significant public health challenges, she has a front-row seat to the realities of the modern healthcare landscape. Her proximity to these hubs of research and policy allows her to scrutinize how government intervention affects the quality of care and the freedom of medical professionals. In Baltimore, she sees the tangible results of policy decisions, using the city as a lens through which to examine the broader national health debate and the impact of federal spending on local communities.
As the lead for the acclaimed feature series “The Cost of Care,” Susan dives deep into the economic realities facing patients and providers alike. Her work focuses on the necessity of price transparency, the benefits of market competition, and the preservation of the sacred doctor-patient relationship. She is a staunch advocate for the idea that a well-informed public is the best defense against bureaucratic inefficiency. Through this series, she has exposed the hidden drivers of rising medical expenses, always seeking to empower the individual consumer over the massive institution.
Susan’s reporting on public policy is characterized by a commitment to rigorous inquiry and a focus on constitutional limits. Whether she is analyzing new pharmaceutical regulations, investigating the impact of federal health mandates, or exploring the future of medical technology, her goal remains the same: to provide Just Right News audiences with the facts they need to navigate a complex world. By blending her Midwestern sensibilities with the insights gained from her base in Maryland, Susan Carter has become a trusted authority for those who believe that personal freedom and public health are inextricably linked. Her work continues to challenge the status quo, advocating for a system that respects the taxpayer and prioritizes the patient.